Journal Article

Restoring Specific Lactobacilli Levels Decreases Inflammation and Muscle Atrophy Markers in an Acute Leukemia Mouse Model

Thissen, Jean-Paul, Delzenne, Nathalie M., Schakman, Olivier, Grangette, Corinne, De Backer, Fabienne, Pachikian, Barbara D., Neyrinck, Audrey M., Scott, Karen P., Cani, Patrice D., Martin, Jennifer C., Pot, Bruno, Dewulf, Evelyne M., Calderon, Pedro Buc, Bindels, Laure B., Beck, Raphaël, Verrax, Julien, Sohet, Florence M.

2012

Overview

The gut microbiota has recently been proposed as a novel component in the regulation of host homeostasis and immunity. We have assessed for the first time the role of the gut microbiota in a mouse model of leukemia (transplantation of BaF3 cells containing ectopic expression of Bcr-Abl), characterized at the final stage by a loss of fat mass, muscle atrophy, anorexia and inflammation. The gut microbial 16S rDNA analysis, using PCR-Denaturating Gradient Gel Electrophoresis and quantitative PCR, reveals a dysbiosis and a selective modulation of Lactobacillus spp. (decrease of L. reuteri and L. johnsonii/gasseri in favor of L. murinus/animalis) in the BaF3 mice compared to the controls. The restoration of Lactobacillus species by oral supplementation with L. reuteri 100-23 and L. gasseri 311476 reduced the expression of atrophy markers (Atrogin-1, MuRF1, LC3, Cathepsin L) in the gastrocnemius and in the tibialis, a phenomenon correlated with a decrease of inflammatory cytokines (interleukin-6, monocyte chemoattractant protein-1, interleukin-4, granulocyte colony-stimulating factor, quantified by multiplex immuno-assay). These positive effects are strain- and/or species-specific since L. acidophilus NCFM supplementation does not impact on muscle atrophy markers and systemic inflammation. Altogether, these results suggest that the gut microbiota could constitute a novel therapeutic target in the management of leukemia-associated inflammation and related disorders in the muscle.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Abl protein / Acids / Acute Disease / Adenoviruses / Animals / Anorexia / Atrophy / Autophagy / Bacteria / BCR protein / BCR-ABL protein / Biology / Body fat / Cancer / Cathepsin L / Cathepsins / Cells, Cultured / Chemokines / Colony-stimulating factor / Cytokines / Dendritic cells / Dietary Supplements / Disease Models, Animal / Dysbacteriosis / Eating disorders / Ectopic expression / Female / Fusion protein / Fusion Proteins, bcr-abl - genetics / Gastrointestinal Tract - microbiology / Gel electrophoresis / Granulocyte colony-stimulating factor / Homeostasis / Immunity / Inflammation / Inflammation - etiology / Inflammation - prevention & control / Inflammation Mediators - metabolism / Interleukin / Interleukin 4 / Interleukin 6 / Interleukins / Intestinal microflora / Laboratory animals / Lactobacilli / Lactobacillus - physiology / Leukemia / Leukemia, Experimental - complications / Leukemia, Experimental - genetics / Leukemia, Experimental - pathology / Leukocytes (granulocytic) / Liver Neoplasms - metabolism / Liver Neoplasms - microbiology / Liver Neoplasms - pathology / Liver transplants / Markers / Medicine / Metabolism / Metagenome / Mice / Mice, Inbred BALB C / Microbiota / Microbiota (Symbiotic organisms) / Microorganisms / Monocyte chemoattractant protein / Monocyte chemoattractant protein 1 / Multiplexing / Muscles / Muscular Atrophy - etiology / Muscular Atrophy - prevention & control / Musculoskeletal system / Nutrition research / Permeability / Physiology / Precursor Cells, B-Lymphoid - transplantation / Restoration / rRNA 16S / Splenic Neoplasms - metabolism / Splenic Neoplasms - microbiology / Splenic Neoplasms - pathology / Toxicology / Transplantation / Tumor necrosis factor-TNF / Type 2 diabetes